Cargando…

Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study

BACKGROUND: Genome-wide transcriptome profiling generated by microarray and RNA-Seq often provides deregulated genes or pathways applicable only to larger cohort. On the other hand, individualized interpretation of transcriptomes is increasely pursued to improve diagnosis, prognosis, and patient tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardeux, Vincent, Arslan, Ahmet D, Achour, Ikbel, Ho, Tsui-Ting, Beck, William T, Lussier, Yves A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101571/ https://www.ncbi.nlm.nih.gov/pubmed/25079003 http://dx.doi.org/10.1186/1755-8794-7-S1-S1

Ejemplares similares

‘N-of-1-pathways’ unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine
por: Gardeux, Vincent, et al.
Publicado: (2014)

Dynamic changes of RNA-sequencing expression for precision medicine: N-of-1-pathways Mahalanobis distance within pathways of single subjects predicts breast cancer survival
por: Schissler, A. Grant, et al.
Publicado: (2015)

Integrative genomics analyses unveil downstream biological effectors of disease-specific polymorphisms buried in intergenic regions
por: Li, Haiquan, et al.
Publicado: (2016)

In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment
por: Yang, Xinan, et al.
Publicado: (2014)

N-of-1-pathways MixEnrich: advancing precision medicine via single-subject analysis in discovering dynamic changes of transcriptomes
por: Li, Qike, et al.
Publicado: (2017)

Unethical Conduct of Underpowered Clinical Trials
por: Habibzadeh, Farrokh
Publicado: (2013)

Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
por: Schissler, A. Grant, et al.
Publicado: (2016)

Underpowered samples, false negatives, and unconscious learning
por: Vadillo, Miguel A., et al.
Publicado: (2015)

Remdesivir for COVID-19: challenges of underpowered studies
por: Norrie, John David
Publicado: (2020)

COVID-19: underpowered randomised trials, or no randomised trials?
por: Fretheim, Atle
Publicado: (2021)

237 Studies of epilepsy surgery outcomes are statistically underpowered.
por: Dickey, Adam, et al.
Publicado: (2022)

The discriminatory cost of ICD-10-CM transition between clinical specialties: metrics, case study, and mitigating tools
por: Boyd, Andrew D, et al.
Publicado: (2013)

Underpowered trials in critical care medicine: how to deal with them?
por: Roozenbeek, Bob, et al.
Publicado: (2010)

Current Incentives for Scientists Lead to Underpowered Studies with Erroneous Conclusions
por: Higginson, Andrew D., et al.
Publicado: (2016)

Targeting Next Generations to Change the Common Practice of Underpowered Research
por: Crutzen, Rik, et al.
Publicado: (2017)

Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer
por: He, Xiaolong, et al.
Publicado: (2010)

Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements()
por: Han, Jiali, et al.
Publicado: (2018)

A genome-by-environment interaction classifier for precision medicine: personal transcriptome response to rhinovirus identifies children prone to asthma exacerbations
por: Gardeux, Vincent, et al.
Publicado: (2017)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties
por: He, X, et al.
Publicado: (2014)

PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor
por: Wang, Kankai, et al.
Publicado: (2022)

The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
por: Turner, Rebecca M., et al.
Publicado: (2013)

Underpowered observational studies create confusion regarding clinical impact of surgical interventions
por: Gupta, Saurabh, et al.
Publicado: (2019)

PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells
por: Guo, Jihua, et al.
Publicado: (2015)

Response to Underpowered Observational Studies Create Confusion Regarding Clinical Impact of Surgical Interventions
por: Johnsrud, Daniel O., et al.
Publicado: (2019)

CircFAM120B knockdown inhibits osteosarcoma tumorigenesis via the miR-1205/PTBP1 axis
por: Li, Jia-Ju, et al.
Publicado: (2021)

Triple P-Positive Parenting programs: the folly of basing social policy on underpowered flawed studies
por: Coyne, James C, et al.
Publicado: (2013)

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered
por: Ortiz, Alberto, et al.
Publicado: (2015)

Psd-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2
por: Zheng, Sika, et al.
Publicado: (2012)

Multiple determinants of splicing repression activity in the polypyrimidine tract binding proteins, PTBP1 and PTBP2
por: Keppetipola, Niroshika M., et al.
Publicado: (2016)

Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct proteins under splicing conditions
por: Pina, Jeffrey M., et al.
Publicado: (2022)

Reliable gains? Evidence for substantially underpowered designs in studies of working memory training transfer to fluid intelligence
por: Bogg, Tim, et al.
Publicado: (2015)

Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021)

Reviewing PTBP1 Domain Modularity in the Pre-Genomic Era: A Foundation to Guide the Next Generation of Exploring PTBP1 Structure–Function Relationships
por: Carico, Christine, et al.
Publicado: (2023)

SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity
por: Kim, Jung-Hyun, et al.
Publicado: (2021)

Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial
por: Girlanda, Francesca, et al.
Publicado: (2014)

Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021)

Most oxytocin administration studies are statistically underpowered to reliably detect (or reject) a wide range of effect sizes
por: Quintana, Daniel S.
Publicado: (2020)

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023)

Unfounded authority, underpowered studies, and non-transparent reporting perpetuate the Mozart effect myth: a multiverse meta-analysis
por: Oberleiter, Sandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hv4q4uoc347u5v26fj0ogaoevr